Immunovant posts $153M net loss as R&D spending climbs in fiscal Q1
Go back to Immunovant posts $153M net loss as R&D spending climbs in fiscal Q1| (NASDAQ: IMVT) | Delayed: 36.95 -0.7 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.65 | 52 Week High | $ | |||
| Open | $37.52 | 52 Week Low | $ | |||
| Day High | $38.35 | P/E | N/A | |||
| Day Low | $36.80 | EPS | $ | |||
| Volume | 2,943,790 | |||||
| (NASDAQ: ROIV) | Delayed: 39.77 -0.21 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.98 | 52 Week High | $ | |||
| Open | $40.11 | 52 Week Low | $ | |||
| Day High | $40.71 | P/E | N/A | |||
| Day Low | $39.72 | EPS | $ | |||
| Volume | 32,200,469 | |||||
